- Author(s):
- Organization(s):
JDP Pharma Consulting, LLC
Do we understand the biorelevance of drug dissolution in the lung?
From a scientific perspective, it makes more sense to start with the task of developing a classification system for inhalation products that would identify gaps in quality attributes than to design and implement testing apparatuses and procedures that may not be biorelevant and only add to the cost of product development.